PMID- 32955964 OWN - NLM STAT- MEDLINE DCOM- 20210521 LR - 20221207 IS - 1557-7600 (Electronic) IS - 1096-620X (Linking) VI - 24 IP - 5 DP - 2021 May TI - Administration of Herbarium Mixture (Guazuma ulmifolia/Tecoma stans) on Metabolic Profile in Type 2 Diabetes Mellitus Patients: A Randomized, Double-Blind, Placebo-Controlled Trial. PG - 527-532 LID - 10.1089/jmf.2020.0082 [doi] AB - The use of herbarium mixture has been empirical, and the properties are not yet known. The aim of this study was to evaluate the effect of oral administration of herbarium mixture (Guazuma ulmifolia [G. ulmifolia]/Tecoma stans [T. stans]) on metabolic profile in patients with type 2 diabetes mellitus (T2DM). A randomized, double-blind, placebo-controlled, clinical trial was carried out in 40 patients with T2DM. They were between 40 and 65 years of age, with body mass index (BMI) between 25.0 and 34.9 kg/m(2) and HbA1c >7.0%. BMI, waist circumference, fasting glucose, HbA1c, lipids, kidney, and liver function were measured. The patients were randomly assigned to receive the herbarium mixture (G. ulmifolia/T. stans) 400 mg before each meal, or placebo for 90 days. Herbarium mixture group showed decreased waist circumference (99 +/- 14 vs. 98 +/- 15 cm; P = .019), fasting glucose (12.0 +/- 5.7 vs. 10.3 +/- 5.1 mM; P = .019), and HbA1c (9.9% +/- 2.7% vs. 8.9% +/- 2.5%, P = .002). In conclusion, the administration of herbarium mixture (G. ulmifolia/T. stans) improved the glycemic profile in patients with T2DM. ClinicalTrial registration: NCT03313856 ClinicalTrials.gov. FAU - Pascoe-Gonzalez, Sara AU - Pascoe-Gonzalez S AD - Department of Physiology, Health Science University Center, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico. FAU - Ramos-Zavala, Maria Guadalupe AU - Ramos-Zavala MG AD - Department of Physiology, Health Science University Center, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico. FAU - Buenrostro Ahued, Miguel Angel AU - Buenrostro Ahued MA AD - Department of Physiology, Health Science University Center, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico. FAU - Hernandez-Gonzalez, Sandra Ofelia AU - Hernandez-Gonzalez SO AD - Medical Research Unit in Clinical Epidemiology, Specialties Hospital, Medical Unit of High Specialty, West National Medical Center, Mexican Institute of Social Security, Guadalajara, Mexico. FAU - Cardona-Munoz, Ernesto German AU - Cardona-Munoz EG AD - Department of Physiology, Health Science University Center, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico. FAU - Garcia-Benavides, Leonel AU - Garcia-Benavides L AD - Department of Physiology, Health Science University Center, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico. FAU - Grover-Paez, Fernando AU - Grover-Paez F AD - Department of Physiology, Health Science University Center, Institute of Experimental and Clinical Therapeutics, University of Guadalajara, Guadalajara, Mexico. LA - eng SI - ClinicalTrials.gov/NCT03313856 PT - Journal Article PT - Randomized Controlled Trial DEP - 20200921 PL - United States TA - J Med Food JT - Journal of medicinal food JID - 9812512 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 0 (Hypoglycemic Agents) SB - IM MH - *Bignoniaceae/metabolism MH - Blood Glucose MH - *Diabetes Mellitus, Type 2/drug therapy MH - Double-Blind Method MH - Glycated Hemoglobin/metabolism MH - Humans MH - Hypoglycemic Agents MH - Metabolome OTO - NOTNLM OT - G. ulmifolia OT - HbA1c OT - T. stans OT - glucose OT - type 2 diabetes EDAT- 2020/09/22 06:00 MHDA- 2021/05/22 06:00 CRDT- 2020/09/21 17:12 PHST- 2020/09/22 06:00 [pubmed] PHST- 2021/05/22 06:00 [medline] PHST- 2020/09/21 17:12 [entrez] AID - 10.1089/jmf.2020.0082 [doi] PST - ppublish SO - J Med Food. 2021 May;24(5):527-532. doi: 10.1089/jmf.2020.0082. Epub 2020 Sep 21.